Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.43 |
| ▸ | CNR2 | P34972 | 8/20 | 0.41 |
| ▸ | CNR1 | P21554 | 6/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7737889 | 0.81 | ACMSD (0.46) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL28431228 | 0.79 | SPHK1 (0.66) | TSHRSPHK1 | |
| SCHEMBL28063060 | 0.78 | SPHK1 (0.68) | TSHRSPHK1 | |
| SCHEMBL9405640 | 0.77 | TYR (0.72) | TYRMEN1TP53CYP3A4ALOX5 | |
| Bicarbonate SCHEMBL10775613 | 0.76 | SPHK1 (0.58) | MEN1MAPTKMT2ASPHK1 | |
| SCHEMBL27809930 | 0.75 | ACMSD (0.48) | TYRCNR2CNR1 | |
| SCHEMBL28160529 | 0.74 | SPHK1 (0.71) | TP53CYP3A4SPHK1 | |
| SCHEMBL11278530 | 0.74 | SPHK1 (0.71) | TP53CYP3A4SPHK1 | |
| 4-Octylphenol SCHEMBL9496711 | 0.74 | ESR1 (0.65) | TP53CYP3A4SPHK1 | |
| SCHEMBL20903897 | 0.74 | SPHK1 (0.43) | MEN1MAPTKMT2ASPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030191349-A1 | Process for the preparation of phenylphenol compounds | CIBA SPECIALTY CHEMICALS CORP. | 2003-10-09 | — | — | US | disclosed |
| EP-1313689-A1 | PROCESS FOR THE PREPARATION OF PHENYLPHENOL COMPOUNDS | Ciba SC Holding AG (CH) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002018311-A1 | PROCESS FOR THE PREPARATION OF PHENYLPHENOL COMPOUNDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-03-07 | — | — | WO | disclosed |
| EP-0852486-A2 | ANTIPLAQUE ORAL COMPOSITION | Colgate-Palmolive Company (US) | 1998-07-15 | — | — | EP | disclosed |
| US-5723500-A | WATER INSOLUBLE, NONCATIONIC, ANTIBACTERIAL, STERICALLY HINDERED PHENOL; MOUTHWASHES, DENTIFRICES | COLGATE-PALMOLIVE COMPANY (US) | 1998-03-03 | — | — | US | disclosed |
| WO-1997010800-A2 | ANTIPLAQUE ORAL COMPOSITION | COLGATE-PALMOLIVE COMPANY (US) | 1997-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030191349-A1 | Process for the preparation of phenylphenol compounds | PAH, CYP1A1, CYP2D6 | TYR 15/4885MEN1 4841/4885TP53 4306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.